Back to Top
Actoxumab Biosimilar - Research Grade
$710.00 - $6,900.00
Actoxumab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
toxin A [Clostridioides difficile]
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Shipping Conditions
Blue ice
Background
Clostridioides difficile toxin A is an enterotoxin that damages the intestinal epithelium and is studied in infection biology and toxin-neutralization research. Offered as an unconjugated, non-therapeutic analog of actoxumab, this research-grade anti-toxin A recombinant monoclonal antibody is intended for research use only (RUO). It is manufactured to in vivo standards, formulated for low endotoxin, and supplied in scalable milligram (mg) to gram (g) quantities for high-throughput and heavy-usage laboratories. Applications include toxin-binding and neutralization assays, in vitro functional screening, and in vivo infection models requiring a consistent, reproducible reagent.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review














